London, United Kingdom

Richard Woolf

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Richard Woolf: Innovator in T Cell Expansion

Introduction

Richard Woolf is a notable inventor based in London, GB. He has made significant contributions to the field of immunology, particularly in the expansion of γδ T cells. With a total of 3 patents, his work has the potential to impact therapeutic approaches in cancer treatment.

Latest Patents

Woolf's latest patents include innovative methods for expanding γδ T cells from non-haematopoietic tissue sources. The first patent, titled "Expansion of γδ T cells, compositions, and methods of use thereof," provides methods for expanding these cells and outlines compositions and applications in adoptive T cell therapy. The second patent, similarly titled, also focuses on the expansion of γδ T cells and their therapeutic uses.

Career Highlights

Throughout his career, Richard Woolf has worked with prestigious institutions such as King's College London and Gammadelta Therapeutics Ltd. His research has been pivotal in advancing the understanding and application of γδ T cells in medical therapies.

Collaborations

Woolf has collaborated with esteemed colleagues, including Adrian Hayday and Oliver Nussbaumer, contributing to the advancement of immunological research.

Conclusion

Richard Woolf's innovative work in expanding γδ T cells showcases his commitment to advancing medical science. His patents and collaborations highlight his significant role in the field of immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…